Literature DB >> 8160727

Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.

R Shomrat1, E Gluck, C Legum, Y Shiloh.   

Abstract

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the X-linked dystrophin gene. The most common mutations in western populations are deletions that are spread non-randomly throughout the gene. Molecular analysis of the dystrophin gene structure by hybridization of the full length cDNA to Southern blots and by PCR in 62 unrelated Israeli male DMD/BMD patients showed deletions in 23 (37%). This proportion is significantly lower than that found in European and North American populations (55-65%). Seventy-eight percent of the deletions were confined to exons 44-52, half of these to exons 44-45, and the remaining 22% to exons 1 and 19. There was no correlation between the size of the deletion and the severity of the disease. All the deletions causing frameshift resulted in the DMD phenotypes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160727     DOI: 10.1002/ajmg.1320490403

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy.

Authors:  Peter J Taylor; Sarah Maroulis; Glenda L Mullan; Robyn L Pedersen; Aurora Baumli; George Elakis; Sara Piras; Corrina Walsh; Benito Prósper-Gutiérrez; Fernando De La Puente-Alonso; Christopher G Bell; David R Mowat; Heather M Johnston; Michael F Buckley
Journal:  J Med Genet       Date:  2007-01-26       Impact factor: 6.318

2.  Deletional mutations of dystrophin gene and carrier detection in eastern India.

Authors:  Jayasri Basak; Uma B Dasgupta; Subhash Chandra Mukherjee; Shyamal Kumar Das; Asit Kumar Senapati; Tapas Kumar Banerjee
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

3.  DMD-related muscular dystrophy in Cameroon: Clinical and genetic profiles.

Authors:  Edmond Wonkam-Tingang; Séraphin Nguefack; Alina I Esterhuizen; David Chelo; Ambroise Wonkam
Journal:  Mol Genet Genomic Med       Date:  2020-06-15       Impact factor: 2.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.